The role of fast axonal transport in acrylamide pathophysiology: Mechanism or epiphenomenon?

被引:33
作者
LoPachin, RM [1 ]
机构
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Anesthesiol, Bronx, NY 10467 USA
关键词
D O I
10.1016/S0161-813X(02)00024-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:253 / 257
页数:5
相关论文
共 28 条
[1]   NEUROTOXICITY OF GLYCIDAMIDE, AN ACRYLAMIDE METABOLITE, FOLLOWING INTRAPERITONEAL INJECTIONS IN RATS [J].
ABOUDONIA, MB ;
IBRAHIM, SM ;
CORCORAN, JJ ;
LACK, L ;
FRIEDMAN, MA ;
LAPADULA, DM .
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1993, 39 (04) :447-464
[2]   Metabolism, toxicokinetics and hemoglobin adduct formation in rats following subacute and subchronic acrylamide dosing [J].
Barber, DS ;
Hunt, JR ;
Ehrich, MF ;
Lehning, EJ ;
LoPachin, RM .
NEUROTOXICOLOGY, 2001, 22 (03) :341-353
[3]   ACRYLAMIDE NEUROPATHY IN THE RAT - EFFECTS ON ENERGY-METABOLISM IN SCIATIC-NERVE [J].
BRIMIJOIN, WS ;
HAMMOND, PI .
MAYO CLINIC PROCEEDINGS, 1985, 60 (01) :3-8
[4]   The impact of dose rate on the neurotoxicity of acrylamide: The interaction of administered dose, target tissue concentrations, tissue damage, and functional effects [J].
Crofton, KM ;
Padilla, S ;
Tilson, HA ;
Anthony, DC ;
Raymer, JH ;
MacPhail, RC .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1996, 139 (01) :163-176
[5]   IONS AND ENERGY IN MAMMALIAN BRAIN [J].
ERECINSKA, M ;
SILVER, IA .
PROGRESS IN NEUROBIOLOGY, 1994, 43 (01) :37-71
[6]  
GOODSON HV, 1994, J CELL SCI, V107, P1875
[7]   KINESIN-RELATED GENE UNC-104 IS REQUIRED FOR AXONAL-TRANSPORT OF SYNAPTIC VESICLES IN C-ELEGANS [J].
HALL, DH ;
HEDGECOCK, EM .
CELL, 1991, 65 (05) :837-847
[8]  
Hurd DD, 1996, GENETICS, V142, P195
[9]   INHIBITION OF SODIUM-POTASSIUM-ATPASE - A POTENTIALLY UBIQUITOUS MECHANISM CONTRIBUTING TO CENTRAL-NERVOUS-SYSTEM NEUROPATHOLOGY [J].
LEES, GJ .
BRAIN RESEARCH REVIEWS, 1991, 16 (03) :283-300
[10]   Biochemical and morphologic characterization of acrylamide peripheral neuropathy [J].
Lehning, EJ ;
Persaud, A ;
Dyer, KR ;
Jortner, BS ;
LoPachin, RM .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 151 (02) :211-221